Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reducing the risks for contrast-induced nephropathy.

Fulvio Stacul1

  • 1University of Trieste, Department of Radiology, Ospedale di Cattinara, Strada di Fiume -34149, Trieste, Italy. fulvio.stacul@aots.sanita.fvg.it

Cardiovascular and Interventional Radiology
|January 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of positive gastrointestinal contrast media. Updated guidelines by the ESUR Contrast Media Safety Committee.

European radiology·2026
Same author

Safety and evidence of CO<sub>2</sub> as a vascular contrast agent as an alternative to iodine-based contrast media in vascular procedures: a systematic review by the ESUR Contrast Medium Safety Committee.

European radiology·2025
Same author

Hypersensitivity reactions to contrast media: Part 2. Prevention of recurrent hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee.

European radiology·2025
Same author

Hypersensitivity reactions to contrast media: Part 1. Management of immediate and non-immediate hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee.

European radiology·2025
Same author

Correction to: SIRM‑SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media.

Clinical and molecular allergy : CMA·2024
Same author

Contrast media for hysterosalpingography: systematic search and review providing new guidelines by the Contrast Media Safety Committee of the European Society of Urogenital Radiology.

European radiology·2024
Same journal

Precision of Ablation Margin Assessment After Liver Microwave Ablation: A Head-to-Head Comparison of Visual and Software-Assisted Methods.

Cardiovascular and interventional radiology·2026
Same journal

Stereotactic Microwave Ablation of Early-Stage Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts: A Matched Case-Control Study.

Cardiovascular and interventional radiology·2026
Same journal

Interventional Radiologist-Directed Sedation Versus General Anesthesia for Percutaneous Biliary Drainage: Effects on Procedural Efficiency and Hemodynamic Stability.

Cardiovascular and interventional radiology·2026
Same journal

Safety and Effectiveness in 400 Image-Guided Spleen Biopsies from the DeGIR Registry.

Cardiovascular and interventional radiology·2026
Same journal

Predilation-Free Scoring Paclitaxel-Coated Balloon Versus Conventional Plain Balloon Angioplasty for Failing Arteriovenous Access: A Multicenter Randomized Controlled Trial.

Cardiovascular and interventional radiology·2026
Same journal

ECIO 2026 Book of Abstracts.

Cardiovascular and interventional radiology·2026
See all related articles

Preventing contrast-induced nephropathy (CIN) involves identifying patient risk factors and using appropriate strategies like hydration. While some treatments are unproven, understanding risk factors and CM types is key to reducing CIN incidence.

Area of Science:

  • Nephrology
  • Radiology
  • Clinical Medicine

Background:

  • Contrast-induced nephropathy (CIN) is a significant adverse event linked to contrast media (CM) use.
  • CIN leads to increased morbidity, mortality, prolonged hospitalization, and poor long-term outcomes.
  • Identifying CIN risk factors is crucial for implementing effective prevention strategies.

Purpose of the Study:

  • To review simple strategies for preventing CIN in at-risk patients.
  • To discuss unproven interventions for CIN prevention.
  • To highlight the importance of identifying patient-related risk factors for CIN.

Main Methods:

  • Review of existing literature on CIN prevention strategies.
  • Identification and discussion of patient-related risk factors for CIN.

Related Experiment Videos

  • Analysis of the impact of contrast media type and dose on CIN development.

    • Main Results:

    • Key risk factors for CIN include elevated serum creatinine, diabetic nephropathy, dehydration, congestive heart failure, older age, and concurrent nephrotoxic medication use.
    • Adequate hydration is a recognized preventive measure, though optimal regimens are debated.
    • Isoosmolar CM may be less nephrotoxic than low-osmolar CM in specific patient groups, requiring further verification.

    Conclusions:

    • CIN prevention relies on identifying high-risk patients and employing strategies like hydration and judicious CM selection.
    • Many pharmacologic agents have not demonstrated efficacy in preventing CIN.
    • Further research is needed to confirm the benefits of isoosmolar CM and clarify the role of agents like N-acetylcysteine.